Found: 11
Select item for more details and to access through your institution.
The Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone Increases Bone Resorption in Women with Type 2 Diabetes: A Randomized, Controlled Trial.
- Published in:
- Calcified Tissue International, 2010, v. 86, n. 5, p. 343, doi. 10.1007/s00223-010-9352-5
- By:
- Publication type:
- Article
Aortic root spontaneous echocardiographic contrast due to haemodynamic support with a percutaneous left ventricular assist device (TandemHeart)
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Aortic root spontaneous echocardiographic contrast due to haemodynamic support with a percutaneous left ventricular assist device (TandemHeart).
- Published in:
- European Journal of Echocardiography, 2011, v. 12, n. 4, p. E28, doi. 10.1093/ejechocard/jer001
- By:
- Publication type:
- Article
Randomized comparison of the effects of rosiglitazone vs. placebo on peak integrated cardiovascular performance, cardiac structure, and function.
- Published in:
- European Heart Journal, 2010, v. 31, n. 18, p. 2262, doi. 10.1093/eurheartj/ehq228
- By:
- Publication type:
- Article
Effect of treatment with rosiglitazone on high-sensitivity cardiac troponin levels among patients with type 2 diabetes mellitus.
- Published in:
- Diabetes & Vascular Disease Research, 2016, v. 13, n. 2, p. 113, doi. 10.1177/1479164115618517
- By:
- Publication type:
- Article
Is cardiorespiratory fitness a determinant of cardiomyopathy in the setting of type 2 diabetes?
- Published in:
- Diabetes & Vascular Disease Research, 2014, v. 11, n. 5, p. 343, doi. 10.1177/1479164114540924
- By:
- Publication type:
- Article
The effects of rosiglitazone on myocardial triglyceride content in patients with type 2 diabetes: A randomised, placebo-controlled trial.
- Published in:
- Diabetes & Vascular Disease Research, 2012, v. 9, n. 2, p. 131, doi. 10.1177/1479164111428628
- By:
- Publication type:
- Article
Assessment of cardiac structure and function in patients without and with peripheral oedema during rosiglitazone treatment.
- Published in:
- Diabetes & Vascular Disease Research, 2011, v. 8, n. 2, p. 101, doi. 10.1177/1479164111403334
- By:
- Publication type:
- Article
The effect of rosiglitazone on integrated cardiovascular performance, cardiac structure, function and myocardial triglyceride: trial design and rationale.
- Published in:
- Diabetes & Vascular Disease Research, 2009, v. 6, n. 1, p. 43, doi. 10.3132/dvdr.2009.009
- By:
- Publication type:
- Article
Current status of risk stratification methods in acute coronary syndromes.
- Published in:
- Current Cardiology Reports, 2006, v. 8, n. 4, p. 282, doi. 10.1007/s11886-006-0060-8
- By:
- Publication type:
- Article
Choice of Imaging Modality in the Assessment of Coronary Artery Disease Risk in Extreme Obesity.
- Published in:
- Obesity (19307381), 2010, v. 18, n. 1, p. 1, doi. 10.1038/oby.2009.150
- By:
- Publication type:
- Article